Wij zijn onze website aan het vernieuwen.

Ontdekt u nog een pagina die niet klopt of hebt u een goede suggestie, laat het ons dan weten via webmedia@umcutrecht.nl.

Deze website maakt gebruik van cookies

Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Lees meer over het cookiebeleid.

prof. dr. H.M. (Helena) Verkooijen Full Professor

  • Clinical Trial Office
  • Department of Epidemiology
  • Julius Center Research Program Cancer

H.M. Verkooijen


Research Programs


Professor of Evaluation of Image-Guided Treatment, dedicated to improve the life of people with cancer. Committed to full integration of clinical research in routine patient care in order to facilitate undelayed evidence-based implementation of innovations in oncology.

Leader (PI) of several international (H2020) research consortia and academic industrial partnership, head of clinical research office and investigator in a range of (international) scientific studies. Strong background in teaching and development of educational modules at graduate and postgraduate level. Large international academic experience in Europe and Asia. Experienced speaker, moderator, and panel member.

Within the Division of Imaging and Cancer of the UMC Utrecht, I am responsible for clinical evaluation of innovative cancer treatments, and for evaluating to what extent theoretical benefits of these innovations translate into real benefits for patients. I lead a team of post-doc researchers, PhD students, and (medical) graduate students. I also lead the division’s clinical research office, which is responsible for trial support, data management, IT solutions, quality control and medico-ethical advise (supporting 200 academic researchers).

I lead two international consortia (one H2020 European, one transatlantic) and collaborate closely with (international) academic and industry partners. I am regularly invited as speaker at international conferences, educational sessions and consortium meetings, and as panelist at meetings/debates of professional organizations. I serve as a member in several scientific advisory boards and expert committees.

I am Strategic Advisor for 'NTvG Gezonde Zorg', a campaign of the Dutch Journal of Medicine (Nederlands Tijdschrift voor Geneeskunde). This campaign contributes to ensuring sustainability and affordability of health care in the Netherlands by exposing the harms of medicalisation (overdiagnosis and overtreatment) and explicitly demonstrating the power of (primary) prevention. 

Side Activities

    • Strategic Advisor 'NTvG Gezonde Zorg'
    • Board Member Dutch Breast Cancer Research Group (Borstkanker Onderzoek Groep, BOOG)
    • Member Scientific Advisory Board Dutch Expert Centre for Screening
    • Board Member J.M. Fentener van Vlissingen Fonds
    • Member Scientific Advisory Board Dutch Prospective Colorectal Cancer Cohort (PLCRC)
    • Member Expert Committee Value-Based Health Care Breast Cancer (NFU)

Research Output (245)

The trials within cohorts design facilitated efficient patient enrollment and generalizability in oncology setting

Couwenberg Alice M, Burbach Johannes P M, May Anne, Berbee Maaike, Intven Martijn P W, Verkooijen Helena M 1 apr 2020, In: Journal of Clinical Epidemiology. 120 , p. 33-39 7 p.

Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment:a prospective cohort study

Pielkenrood B J, van Urk P R, van der Velden J M, Kasperts N, Verhoeff J J C, Bol G H, Verkooijen H M, Verlaan J J mrt 2020, In: Acta Oncologica. 59 , p. 291-297 7 p.

Stereotactic 9-gauge vacuum-assisted breast biopsy, how many specimens are needed?

den Dekker Bianca M, van Diest Paul J, de Waard Stephanie N, Verkooijen Helena M, Pijnappel Ruud M nov 2019, In: European Journal of Radiology. 120

Introducing the CONsolidated Standards of Reporting Trials (CONSORT) statement for randomised controlled trials (RCTs) using cohorts and routinely collected health data

Juszczak Edmund, Kwakkenbos Linda, McCall Stephen, Imran Mahrukh, Hemkens Lars G., Zwarenstein Merrick, Frobert Ole, Relton Clare, Sampson Margaret, Thabane Chair Lehana, Benchimol Eric I., Campbell Marion K., Torgerson David J., Erlinge David, Rice Danielle B., Langan Sinead, Mc Cord Kimberly A., van Staa Tjeerd P., Moher David, Verkooijen Helena M., Uher Rudolf, Worron-Sauve Maureen B., Boutron Isabelle, Ravaud Philippe, Thombs Brett D., Gale Chris okt 2019, 20

Self-reported work ability in breast cancer survivors; a prospective cohort study in the Netherlands

Gregorowitsch M L, van den Bongard H J G D, Couwenberg A M, Young-Afat D A, Haaring C, Van Dalen T, Schoenmaeckers E J P, Agterof M J, Baas I O, Sier M F, Ernst M F, van Hummel R, Verkooijen H M, 28 aug 2019, In: The Breast. 48 , p. 45-53 9 p.

Bragatston study protocol:a multicentre cohort study on automated quantification of cardiovascular calcifications on radiotherapy planning CT scans for cardiovascular risk prediction in patients with breast cancer

Emaus Marleen J, Išgum Ivana, van Velzen Sanne G M, van den Bongard H J G Desirée, Gernaat Sofie A M, Lessmann Nikolas, Sattler Margriet G A, Teske Arco J, Penninkhof Joan, Meijer Hanneke, Pignol Jean-Philippe, Verkooijen Helena M, 1 jul 2019, In: BMJ Open. 9

Breast Edema Following Breast-Conserving Surgery and Radiotherapy:Patient-Reported Prevalence, Determinants, and Effect on Health-Related Quality of Life

Young-Afat Danny A, Gregorowitsch Madelijn L, van den Bongard Desirée H, Burgmans Ine, van der Pol Carmen C, Witkamp Arjen J, Bijlsma Rhodé M, Koelemij Ron, Schoenmaeckers Ernst J, Jonasse Yvette, van Gils Carla H, Verkooijen Helena M jun 2019, In: JNCI cancer spectrum. 3

The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients

Gregorowitsch M L, Ghedri A, Young-Afat D A, Bijlsma R, Baas I O, van Schaik-van de Mheen C, Agterof M J, Göker E, Ten Bokkel Huinink D, van den Bongard H J G D, Verkooijen H M, jun 2019, In: Breast Cancer Research and Treatment. 175 , p. 429-441 13 p.

Behandeling voor kanker:er valt iets te kiezen

Boersma Liesbeth J., Sonke Gabe S., Verkooijen Helena M. 31 mei 2019, In: Nederlands Tijdschrift voor Geneeskunde. 163

Systematic review of the role of stereotactic radiotherapy for bone metastases

Spencer Katie, van der Velden Joanne M, Wong Erin, Seravalli Enrica, Sahgal Arjun, Chow Edward, Verlaan Jorrit-Jan, Verkooijen Helena M, van der Linden Yvette M 23 mei 2019, In: Journal of the National Cancer Institute. 111 , p. 1023-1032 10 p.

All Research Output (245)
To top